ARCHIVES

FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

NCI blocked groups from phase III Iressa studies.

April 30, 2004

Research Needed To Improve Survival In Adolescents, Young Adults With Cancer

January 26, 2007

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980

St. Jude Offers Three Fellowships

May 3, 1985

In Brief: Bishop No Longer Candidate For NCI Director; HHS Endorses Intramural Scientist Klausner

April 21, 1995